Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12...
Bionomics Limited (Nasdaq: BNOX, ASX: BNO), a clinical-stage biopharmaceutical developing novel, allosteric ion channel modulators designed to...
Bionomics Limited (ASX:BNO, NASDAQ:BNOX) (Bionomics or Company), a clinical-stage biopharmaceutical company, participated in the H.C Wainwright...
Bionomics Limited (Bionomics or Company), a clinical-stage biopharmaceutical company, today announced the issuance of 243,300 American Depositary...
Bionomics Limited (ASX: BNO, NASDAQ: BNOX) (Bionomics or Company), a clinical-stage biopharmaceutical company, is pleased to announce that it has...
Bionomics Limited (Bionomics or Company), a clinical-stage biopharmaceutical company, today announced the pricing of its initial public offering in...
Bionomics Limited (Bionomics or Company), a clinical-stage biopharmaceutical company, today announced the launch of its initial public offering (the...
Bionomics Limited (ASX:BNO, OTCQB:BNOEF) (Bionomics or Company), a clinical-stage biopharmaceutical company, is pleased to announce that the U.S....
Bionomics Limited (ASX:BNO, OTCQB:BNOEF) (Bionomics or Company), a clinical-stage biopharmaceutical company, today announced the public filing of a...
Bionomics Limited (ASX:BNO, OTCQB:BNOEF) (Bionomics or Company), a clinical-stage biopharmaceutical company, is pleased to announce that it has...
Bionomics Limited (ASX: BNO, OTCQB:BNOEF) (Bionomics or Company), a clinical-stage biopharmaceutical company, is pleased to announce that as part of...
Bionomics Limited (ASX: BNO, OTCQB: BNOEF), (Bionomics) a global, clinical stage biopharmaceutical company, is pleased to announce that it plans to...
Bionomics Limited (ASX: BNO, OTCQB:BNOEF) (Bionomics or Company), a global, clinical stage biopharmaceutical company, is pleased to announce that it...
Bionomics Limited (OTCQB:BNOEF) (Bionomics or Company), a global, clinical stage biopharmaceutical company, is pleased to announce that as part of...
Bionomics Limited (ASX: BNO, OTCQB:BNOEF) (Bionomics) has completed its 1 for 6 pro rata non–renounceable entitlement offer that was announced on 8...
Bionomics Limited (ASX: BNO, OTCQB: BNOEF, Germany: AU000000BNO5), a global, clinical stage biopharmaceutical company, today announced positive...
Bionomics Limited (ASX: BNO, OTCQB: BNOEF, Germany: AU000000BNO5) (Bionomics) today announced that it has entered into a Memorandum of Understanding...
Bionomics Limited (ASX: BNO, OTCQB: BNOEF, Germany: AU000000BNO5), a global, clinical stage biopharmaceutical company, is pleased to announce that it ...
Bionomics Limited (ASX:BNO) (OTCQX:BNOEF), a global, clinical stage biopharmaceutical company, today announces that a Phase 2 clinical trial of its...
Bionomics Limited (ASX:BNO, OTCQX:BNOEF), a biopharmaceutical company focused on the discovery and development of innovative therapeutics for the...
A substantial additional market opportunity for BNC210 has been identified and will be developed via a Phase 2 trial funded by a US$12m placement...
Bionomics Limited (ASX:BNO, ADR:BMICY), a biopharmaceutical company focused on the discovery and development of innovative therapeutics for the...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.